Valeant to sell assets for $2.12 billion to ease debt load | International News Live Blog

https://internationalnewsliveblog.wordpress.com/2017/01/10/valeant-to-sell-assets-for-2-12-billion-to-ease-debt-load/

(Reuters) – Valeant Pharmaceuticals International is selling its Dendreon cancer business and three skincare brands for about $2.12 billion as the troubled Canadian drugmaker looks to pay down its more than $30 billion debt. http://internationalnewslive.com/valeant-to-sell-assets-for-2-12-billion-to-ease-debt-load/